The goal of the IHMC http://www.human-microbiome.org/ is to work under a common set of principles and policies to study and understand the role of the human microbiome in the maintenance of health and causation of disease and to use that knowledge to improve the ability to prevent and treat disease. The Consortium’s efforts are focused on generating a shared comprehensive data resource that will enable investigators to characterize the relationship between the composition of the human microbiome (or of parts of the human microbiome) and human health and disease.
IHMC 2018 (June 26-28) is a platform to highlight the latest advances and challenges in microbiome research from discovery to delivery. The event will cover a wide range of themes including: Microbiota for molecules and therapeutics, Live Biotherapeutics, Microbiome-host interactions, Analyzing microbiome and host data, Diseases including Cancer, HIV & IBD.
Rob Knight is a Professor in the Department of Pediatrics, with an additional appointment in the Department of Computer Science, at the University of California San Diego.
Colin Hill is a Professor of Microbial Food Safety in the School of Microbiology at University College Cork, Ireland and a Principal Investigator in the APC Microbiome Ireland.
Emily Vogtmann is a Research Fellow in the Metabolic Epidemiology Branch of the Division of Cancer Epidemiology & Genetics at the National Cancer Institute.
Eran Segal is a faculty member in the Department of Computer Science and Applied Mathematics at The Weizmann Institute of Science, Rehovot, Israel.
John F. Cryan is Professor & Chair, Dept. of Anatomy & Neuroscience, University College Cork and a Principal Investigator in the APC Microbiome Ireland.
Julie Segre is a Senior Investigator, Genetics and Molecular Biology Branch, at The National Human Genome Research Institute.
Sarkis Mazmanian is a medical microbiologist at the California Institute of Technology since 2006, and is currently the Louis & Nelly Soux Professor of Microbiology in the Division of Biology and Biological Engineering.
|Susan V Lynch|
Dr. Lynch is an Associate Professor of Medicine, at the University of California San Francisco, where she also Directs the Microbiome Research Core and acts as Associate Director of the Microbiome in Inflammatory Disease Program.
Matthew Henn is the Executive Vice President, Microbiome R&D at Seres.
Alex Stevenson is the Chief Scientific Officer on the Board of Directors for 4D Pharma PLC.
Chaysavaahn is the head of the Metagenomics Lab, Department of Physiology and Physiopathology, Vall d’Hebron Research Institute (VHIR), in Barcelona.
Christian is the Professor of Medicine and Program Leader, Cancer Microbiota & Host Response, UF Health Cancer Center
Elhanan is Associate Professor of Genome Sciences and Adjunct Associate Professor of Computer Science at the University of Washington.
Eric is the Head of the Division of Subspecialty Medicine andEnid A. Haupt Chair in Clinical Investigation at the Memorial Sloan Kettering Hospital, New York.
Janet Jansson is the Division Director of Biological Sciences at the Pacific Northwest National Laboratory (PNNL). She is also PNNL’s sector manager for the U.S. Department of Energy Office of Biological and Environmental Research’s Biological Systems Science Division.
Kjersti is an Associate Professor at the Baylor College of Medicine in Houston, Texas.
|Rochellys Diaz Heitz|
Rochellys is an Associate Professor in the Department of Neuroscience at the Karolinska Institutet in Stockholm.
Prof Liping Zhao is currently a professor for microbiology and associate dean for School of Life Sciences and Biotechnology, Shanghai Jiao Tong University. He is also the leader for the functional Metagenomics platform in Shanghai Center for Systems Biomedicine.
Dr. Lozupone is in the Division of Biomedical Informatics and Personalized Medicine in the Department of Medicine, and is additionally core faculty in the Computational Biosciences Program and adjunct faculty in the Department of Microbiology, University College Denver.
Emily is currently the Morris Kahn Associate Professor of Chemistry and Chemical Biology. She is also an Associate Member of the Broad Institute of Harvard and MIT, a Faculty Associate of the Microbial Sciences Initiative at Harvard, and a member of the Harvard Digestive Diseases Center.
Frederic is the William Maul Measey Professor in Microbiology in the Perelman School of Medicine at the University of Pennsylvania.
GwangPyo is Professor of Environmental Health Microbiology Graduate School of Public Health, Seoul National University.
Ines is Associate professor in Systems Biomedicine in the University of Luxembourg.
Joël Doré is an INRA research director. He is also a co-director of the very large Joint Research Unit for Food and Gut Microbiology for Human Health and the scientific director of MetaGenoPolis.
Laurie Comstock is an Associate Professor of Medicine at Harvard Medical School with a primary appointment in the Division of Infectious Diseases, Brigham and Women’s Hospital.
Associate Professor of Microbiology & Molecular Genetics at the School of Medicine, University of California.
Mark is Chair in Microbial Biology and Metagenomics at the University of Queensland Diamantina Institute.
Max is Professor of Internal Medicine and Endocrinology at Academisch Medisch Centrum, Amsterdam.
Peer is Senior scientist and group leader, head of unit for Structural and Computational Biology and Strategic Head of Bioinformatics, at the EMBL Heidelberg and Visiting group leader at the MDC, Berlin-Buch.
Yolanda Sanz is Professor and Head of the Microbial Ecology, Nutrition and Health Research Unit of the National Research Council (IATA-CSIC), Spain.
Lee Jones is the founder, president, and chief executive officer of Rebiotix, a results-oriented biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome.
Curtis is an Associate Professor of Computational Biology and Bioinformatics in the Department of Biostatistics at Harvard University School of Public Health.
As specialist in research on the human microbiome, Denise is responsible for relationships within the scientific and academic communities on behalf of Seventure Partners, identifying new investment opportunities in the field specific to the microbiome.
|E. Scott Stibitz|
Dr. Stibitz is an expert evaluator of Fecal Microbiota Transplantation related investigational new drug (IND) applications at the FDA.
Mike Surette is Professor of Medicine at McMaster University. His laboratory’s primary area of research investigates the role of normal flora-pathogen interactions in health and disease in the area of respiratory infections with a focus in cystic fibrosis.
Dr. Jun Wang, Founder and CEO of iCarbonX. Dr. Wang earned a bachelor’s degree in artificial intelligence and a Ph.D. in bioinformatics from Peking University.
Professor Martin Antonio is the leader of the molecular biology group at the MRC Unit The Gambia and was recently awarded an honorary professorship at the Division of Microbiology & Immunity, Warwick Medical School, Coventry, UK.
Prof Karine Clément is full professor of Nutrition, Division of Cardiometabolism, Pitié-Salpêtrière hospital and at Paris 6 Pierre et Marie Curie university in Paris.
Professor Lanjuan Li is a member of CAE (Chinese Academy of Engineering) and Professor/Chief Physician of Infectious Diseases, The First Affiliated Hospital of Zhejiang University School of Medicine.
Prof Dirk Haller is the Chair of Nutrition and Immunology at TUM School of Life Sciences Weihstephan. The main focus of Prof Haller’s research is on bacteria (microbiota) in the intestine and their role both in chronic inflammatory diseases like Crohn’s disease and in carcinogenesis.
|Tine Rask Licht|
Prof Tine Rask Licht is the Head of Research Group for Gut Microbiology and Immunology, at the National Food Institute, Technical University of Denmark.
Prof Greg Buck is the Director of the Center for the Study of Biological Complexity in Department of Microbiology and Immunology at Virginia Commonwealth University. His research focuses on the genomics and evolution of microbial pathogens and host pathogen interactions.
Bill Mohn is a Professor at the Department of Microbiology & Immunology, University of British Columbia.The Mohn lab studies diverse topics in microbial ecology, including the composition of complex microbial communities in soil and marine environments while working to understand how the composition of communities relates to the important ecological services provided by those communities.
Dr. Olle is a co-founder and Chief Executive Officer of Vedanta Biosciences. He has been a member of the founding teams of several companies of the PureTech portfolio and served as a member of the Board of Directors of Vedanta Biosciences and Follica Biosciences.
Tanja’s work covers a wide range of technical areas within biotechnology. Her clients range from large multinationals to UK start-ups, and she is closely involved with shaping many of her clients’ IP strategies, including those for key commercial products.
Dr. Wargo’s career commitment is to advance the understanding and treatment of disease through science. After completing her medical degree, she entered surgical residency training at the Massachusetts General Hospital/Harvard Medical School where she became interested in the biology and treatment of cancer.
Jun YU is a professor in Department of Medicine and Therapeutics, Faculty of Medicine at The Chinese University of Hong Kong (CUHK). She has been a CUHK faculty member since 2005 and currently as a Professor at Department of Medicine and Therapeutics, director of the Research Laboratory of Institute of Digestive Disease, and associate director of State Key Laboratory of Digestive Disease, CUHK.
Dr. White is an internationally recognized expert in bioinformatics with more than 15 years of experience. His primary role is to enable the researchers at School of Medicine to perform state of the art genomic and transcriptomic analysis at the University of Maryland, School of Medicine. For the last nine years, Dr. White has been the PI for two NIH-funded data centers: first the Data Analysis and Coordination Center for the first phase of the Human Microbiome Project and now the Data Coordination Center for the Integrative Human Microbiome Project.
Liang Xiao works in the Personal Omics department at the BGI Research, Beijing Genomics Institute. His research is focused on the role of the gut microbiome and diet in disease.
Carina is a Policy Officer in the Agri-Food Chain unit of the Directorate-General for Research and Innovation, at the European Commission.
Dr. Versalovic is currently the co-chair of the IHMC. The Versalovic lab seeks to understand the human microbiome and how the microbiome affects mucosal signaling in intestinal inflammation. Diseases of interest include acute gastroenteritis, inflammatory bowel disease, intestinal neoplasia, and irritable bowel syndrome.
Dr. Proctor is currently the co-chair of the IHMC and Program Director of the Human Microbiome Project (HMP).
Further agenda details to follow.